Leukemia Research
Volume 26, Issue 10 , Pages 909-918 , October 2002

Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors

  • Xavier Thomas

      Affiliations

    • Service d’Hématologie Clinique, Hôpital Edouard Herriot, 69437 Lyon Cedex 03, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-4-72117395; fax: +33-4-72117404
    • ,
  • Quoc-Hung Le

      Affiliations

    • Service d’Hématologie Clinique, Hôpital Edouard Herriot, 69437 Lyon Cedex 03, France
    • ,
  • Catalin Danaı̈la

      Affiliations

    • Service d’Hématologie Clinique, Hôpital Edouard Herriot, 69437 Lyon Cedex 03, France
    • ,
  • Véronique Lhéritier

      Affiliations

    • Service d’Hématologie Clinique, Hôpital Edouard Herriot, 69437 Lyon Cedex 03, France
    • ,
  • Martine Ffrench

      Affiliations

    • Laboratoire d’Histologie et de Cytologie Analytique, Hôpital Edouard Herriot, 69437 Lyon Cedex 03, France

Received 22 October 2001 ,Accepted 4 February 2002.

References 

  1. Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, et al.  Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988;71:123–131
  2. Boucheix C, David B, Sebban C, Racadot E, Bené MC, Bernard A, et al.  The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA-87). Blood. 1994;84:1603–1612
  3. Kantarjian HM, Walters RS, Keating MJ, Smith TL, O’Brien S, Estey EH, et al.  Results of the vincristine, doxorubicin and dexamethasone regimen in adults with standard- and high-risk acute lymphoblastic leukemia. J. Clin. Oncol. 1990;8:994–1004
  4. Gaynor J, Chapman D, Little C, McKenzie S, Miller W, Andreeff M, et al.  A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the memorial hospital experience since 1969. J. Clin. Oncol. 1988;6:1014–1030
  5. Rios A, Canizo MC, Sanz MA, Vallespi T, Sanz G, Torrabadella M, et al.  Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors. Br. J. Haematol. 1990;75:26–33
  6. Rozman C, Monserrat E, Rodriguez JM, Ayats R, Vallespi T, Parody R, et al.  Bone marrow histologic-pattern. The best single prognostic parameter in chronic lymphocytic leukemia. A multivariate survival analysis of 329 cases. Blood. 1984;64:642–648
  7. Bartl R, Frisch B, Burkhardt R, Kettner G, Mahl G, Fathed-Moghadan A, et al.  (1982) Assessment of bone marrow histology in the malignant lymphomas (non-Hodgkin): correlation with clinical factors for diagnosis, prognosis, classification and staging. Br. J. Haematol. 1982;51:511–530
  8. Lazzarino M, Morra E, Castello A, Inverardi D, Coci A, Pagnucco G, et al.  Myelofibrosis in chronic granulocytic leukemia: clinicopathologic correlation and prognostic significance. Br. J. Haematol. 1986;64:227–240
  9. Annaloro C, Lambertenghi Deliliers G, Oriani A, Pozzoli E, Lambertenghi Deliliers D, Radaelli F, et al.  Prognostic significance of bone marrow biopsy in essential thrombocythemia. Haematologica. 1999;84:17–21
  10. Frisch B, Bartl R, Burkhardt R. Bone marrow biopsy in clinical medicine: an overview. Haematologica. 1982;3:245–285
  11. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. Br. J. Haematol. 1976;33:451–458
  12. Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Leukemia. 1995;9:249–253
  13. International System for Human Cytogenetic Nomenclature (ISCN). Guidelines for cancer cytogenetics. In: Mitelman F, editor. Supplement to an international system for human cytogenetic nomenclature. Basel: Karger, 1991. p. 1–53.
  14. Hoelzer D, Thiel E, Löffler H, Bodenstein H, Plaumann L, Büchner T, et al.  Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood. 1984;64:38–47
  15. Fiere D, Archimbaud E, Extra JM, Marty M, David B, Witz F, Sotto JJ, Rochant H, Gastaut JA, Le Prise PY. Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French Group. In: Büchner T, et al., editors. Acute leukemias. Prognostic factors and treatment strategies. Springer: Berlin, 1987. p. 125–29.
  16. Fiere D, Marty M, Solal-Celigny P, Harousseau JL, Gorin NC, Desablens B, et al.  Induction massive et consolidation précoce des leucémies aiguës lymphoı̈des de l’adulte. Etude pilote de faisabilité et évolution lointaine. La Presse Médicale. 1989;18:221–223
  17. Fiere D, Lepage E, Sebban C, Boucheix C, Gisselbrecht C, Vernant JP, et al.  Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as post-remission therapy. J. Clin. Oncol. 1993;11:1990–2001
  18. Thomas X, Danaı̈la C, Bach QK, Dufour P, Christian B, Corront B, et al.  (1995b) Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide and prednisone in adult acute lymphoblastic leukemia. Ann. Hematol. 1995;70:65–69
  19. Delannoy A, Sebban C, Cony-Makhoul P, Cazin B, Cordonnier C, Bouabdallah R, et al.  for the French Group for Treatment of Adult Acute Lymphoblastic Leukemia. Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy, A multicentric prospective study in forty patients. Leukemia. 1997;11:1429–1434
  20. Delannoy A, Cazin B, Thomas X, Marit G, Huguet F, Bouabdallah R, et al.  Preliminary results of an age-adapted protocol in elderly patients with acute lymphocytic leukemia (ALL). Blood. 1999;94(suppl.1):227b
  21. Dombret H, Thomas X, Blaise D, Huguet F, Boiron JM, Buzyn A, et al.  Intensive therapy in 100 patients with Ph1 and/or BCR/ABL positive acute lymphoblastic leukemia (ALL): first interim analysis of the French–Belgian–Australian LALA-94 trial. Br. J. Haematol. 1999;102:270
  22. Schauer P, Arlin ZA, Mietelsmann R, Corrincione C, Friedman A, Gee TS, et al.  Treatment of acute lymphoblastic leukemia in adults: Results of the L-10 and L-10M protocols. J. Clin. Oncol. 1983;1:462–470
  23. Stryckmans PA, Otten J, Delbeke MJ, Suciu S, Fiere D, Bury J, et al.  for the EORTC Hemopathies Working Party. Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adults. Blood. 1983;62:606–615
  24. Coiffier B, Bryon PA, Ffrench M, Blanc M, Sebban C, Berger F, et al.  Intensive chemotherapy in aggressive lymphomas: Updated results of LNH-80 protocol and prognostic factors affecting response and survival. Blood. 1987;70:1394–1399
  25. Patte C, Michon J, Frappaz D, Leverger G, Rubie H, Soussain C, et al.  Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Baillière’s Clin. Haematol. 1994;7:339–348
  26. Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J, et al.  Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood. 1968;32:507–523
  27. Bryon PA. Inclusion en époxy des biopsies médullaires pour le diagnostic hématologique. Path. Biol. 1976;24:75–79
  28. Kushida H. A new method for embedding with Epon 812. J. Electr. Microsc. 1971;20:206–207
  29. Kaplan EL, Meier P. Nonparametric estimation form in complete observations. J. Am. Stat. Assoc. 1958;53:457–481
  30. Cox DR. Regression model of life tables. J. R. Stat. Soc. 1972;34:187–220
  31. Colly LP, Peters WG, Hermans J, Arentsen-Honders W, Willemze R. Percentage of S-phase cells in bone marrow aspirates, biopsy specimens and bone marrow aspirates corrected for blood dilution from patients with acute leukemia. Leuk. Res. 1987;11:209–213
  32. Murphy SB, Aur RJA, Simone JV, George S, Mauer AM. Pretreatment cytokinetic studies in 94 children with acute leukemia. Relationship to other variables at diagnosis and to outcome of standard treatment. Blood. 1977;49:683–691
  33. Scarffe JH, Hann IM, Evans DIK, Morris Jones P, Palmer MK, Lilleyman JS, et al.  Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood. Br. J. Haematol. 1980;41:764–771
  34. Hart JS, George SL, Frei E, Bodey GP, Nickerson RC, Freireich EJ. Prognostic significance of pretreatment proliferative activity in adult acute leukemia. Cancer. 1977;39:1603–1617
  35. Dosik GM, Barlogie B, Smith TL, Gehan EA, Keating M, McCredie K, et al.  Pretreatment flow cytometry of DNA content in adult leukemia. Blood. 1980;55:474–482
  36. Holdrinet RSG, Pennings A, Drenthe-Schonk AM, van Egmond J, Wessels JMC, Haanen C. Flow cytometric determination of S-phase compartment in adult acute leukaemia. Acta Haematol. 1983;70:369–378
  37. Ffrench M, Manel AM, Magaud JP, Fiere D, Adeleine P, Guyotat D, et al.  Adult acute lymphoblastic leukaemia: is cell proliferation related to other clinical and biological features?. Br. J. Haematol. 1987;65:419–423
  38. Welte K, Reiter A, Mempel K, Pfetsch M, Schwab G, Schrappe M, et al.  A randomized phase III study of the efficacy of granulocyte-colony stimulating factor in children with high-risk acute lymphoblastic leukemia. Blood. 1996;87:3143–3150
  39. Ottmann OG, Hoelzer D, Gracien E, Ganser A, Kelly K, Reutzel R. Concomitant granulocyte-colony stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. Blood. 1995;86:444–450
  40. Geissler K, Koller E, Hubmann E, Niederwieser D, Hinterberger W, Geissler D, et al.  Granulocyte-colony stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia—a randomized phase III study. Blood. 1997;90:590–596
  41. Dibenedetto SP, Ragusa R, Ippolito AM, Lo-Nigro L, Dicataldo A, D’Amico S. Assessment of the value of treatment with granuocyte-colony stimulating factor in children with acute lymphoblastic leukemia: a randomized clinical trial. Eur. J. Haematol. 1995;55:93–96
  42. Wallis JP, Reid MM. Bone marrow fibrosis in childhood acute lymphoblastic leukaemia. J. Clin. Pathol. 1989;42:1253–1254

PII: S0145-2126(02)00034-6

Leukemia Research
Volume 26, Issue 10 , Pages 909-918 , October 2002

Article Tools

* Image Usage & Resolution